2.02
price down icon4.27%   -0.09
after-market After Hours: 2.02
loading

Enveric Biosciences Inc Stock (ENVB) Forecast

The Enveric Biosciences Inc (ENVB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $109.48, representing a +5,320% increase from the current price of $2.02. The highest analyst price target is $110.31, and the lowest is $108.65.

Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ENVB Price Target
Average 83.36 (+4,027% Upside)
loading

Is Enveric Biosciences Inc (ENVB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 26.07 Buy
STOCH(9,6) 6.1279 Buy
STOCHRSI(14) 2.3719 Buy
MACD(12,26) -0.6324 Sell
ADX(14) 20.93 Neutral
William %R -97.79 Buy
CCI(14) -70.31 Neutral
Buy: 4 Sell: 1 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
2.50
Sell
2.5223
Sell
MA20
3.2427
Sell
3.0247
Sell
MA50
4.2874
Sell
4.1565
Sell
MA100
5.6828
Sell
6.3497
Sell
MA200
10.05
Sell
14.36
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, ENVB could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ENVB, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 26.07 indicates that ENVB is oversold. This indicates that ENVB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 6.1279 indicates that ENVB is oversold. This indicates that ENVB price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.3719 indicates that ENVB is oversold. This suggests that ENVB price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 20.93 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -70.31 indicates that ENVB is still oversold but not to an extreme extent.

Long-term ENVB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Enveric Biosciences Inc financial reports and earnings history, Enveric Biosciences Inc (ENVB) stock could reach $222.21 by 2030, $854.92 by 2040 and $324.20 by 2050. See the projected annual prices until 2050 of the Enveric Biosciences Inc stock below:

  • Enveric Biosciences Inc (ENVB) is expected to reach an average price of $107.23 in 2035, with a high prediction of $120.50 and a low estimate of $107.36. This indicates an $5,209% rise from the last recorded price of $2.02.
  • Enveric Biosciences Inc (ENVB) stock is projected to chart a bullish course in 2040, with an average price target of $851.49, representing an $42,053% surge from its current level. The forecast ranges from a conservative $854.99 to a sky-high $854.92.
  • Our analysts predict Enveric Biosciences Inc (ENVB) to jump 34,185% by 2045, soaring from $692.84 to an average price of $692.55, potentially reaching $711.15. While $692.84 is the low estimate, the potential upside is significant.
  • Enveric Biosciences Inc (ENVB) stock is expected to climb by 2050, reaching an average of $300.10, a $14,757% jump from its current level. However, a wide range of estimates exists, with high and low targets of $324.20 and $300.41, respectively, highlighting the market's uncertainty.

Enveric Biosciences Inc Stock (ENVB) Year by Year Forecast

Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2026

The predicted value for Enveric Biosciences Inc (ENVB) in 2026 is set at an average of $91.30. Estimates vary from a peak of $115.64 to a trough of $66.96, indicating an +4,420% surge from the present price of $2.02.
Month Average Low High Change from today's price
March, 2026 $108.65 $108.65 $110.31 +5,279%
April, 2026 $104.94 $105.01 $106.45 +5,095%
May, 2026 $100.71 $100.83 $102.93 +4,886%
June, 2026 $96.34 $96.47 $99.23 +4,669%
July, 2026 $91.42 $91.93 $94.97 +4,426%
August, 2026 $86.07 $86.22 $89.61 +4,161%
September, 2026 $81.05 $81.06 $84.80 +3,912%
October, 2026 $76.83 $76.94 $79.83 +3,704%
November, 2026 $72.55 $72.77 $75.61 +3,492%
December, 2026 $64.81 $66.96 $70.84 +3,109%

Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Enveric Biosciences Inc (ENVB) is $34.84, with a high forecast of $61.75 and a low forecast of $7.926. This indicates an +1,625% increase from the last price of $2.02.
Month Average Low High Change from today's price
January, 2027 $59.86 $59.89 $61.75 +2,864%
February, 2027 $56.24 $56.41 $58.40 +2,684%
March, 2027 $51.00 $51.03 $54.83 +2,425%
April, 2027 $46.77 $46.79 $48.46 +2,215%
May, 2027 $41.98 $42.32 $45.52 +1,978%
June, 2027 $36.84 $36.89 $40.71 +1,724%
July, 2027 $32.57 $32.69 $35.58 +1,512%
August, 2027 $27.98 $28.04 $31.36 +1,285%
September, 2027 $22.50 $22.55 $26.83 +1,014%
October, 2027 $18.34 $18.56 $21.35 +808.13%
November, 2027 $13.19 $13.83 $16.93 +552.99%
December, 2027 $7.926 $7.926 $11.60 +292.38%

Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2028

In 2028, Enveric Biosciences Inc (ENVB) is projected to reach an average price of $147.44, with a high projection of $293.71 and a low estimate of $1.1679. This indicates an +7,199% rise from the last price of $2.02.
Month Average Low High Change from today's price
January, 2028 $3.4596 $3.4988 $6.5932 +71.27%
February, 2028 $251.85 $1.1679 $198.40 +12,368%
March, 2028 $219.93 $223.43 $242.07 +10,787%
April, 2028 $245.78 $259.28 $246.85 +12,067%
May, 2028 $298.85 $270.43 $277.85 +14,695%
June, 2028 $313.21 $297.28 $293.71 +15,406%
July, 2028 $280.57 $282.57 $276.85 +13,790%
August, 2028 $271.64 $282.21 $280.50 +13,348%
September, 2028 $283.00 $286.50 $281.28 +13,910%
October, 2028 $270.35 $280.85 $277.22 +13,284%
November, 2028 $254.93 $237.78 $239.43 +12,520%
December, 2028 $260.78 $258.07 $251.28 +12,810%

Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2029

The 2029 price forecast for Enveric Biosciences Inc Stock (ENVB) is $256.79 on average, with a high prediction of $288.54 and a low estimate of $225.04. This represents an +12,612% increase from the previous price of $2.02.
Month Average Low High Change from today's price
January, 2029 $265.35 $254.93 $255.35 +13,036%
February, 2029 $269.71 $271.57 $268.71 +13,252%
March, 2029 $282.13 $273.43 $273.57 +13,867%
April, 2029 $279.43 $280.43 $280.56 +13,733%
May, 2029 $286.10 $286.12 $288.54 +14,063%
June, 2029 $273.35 $273.85 $281.46 +13,432%
July, 2029 $266.79 $267.09 $270.70 +13,107%
August, 2029 $258.99 $260.68 $264.08 +12,721%
September, 2029 $250.82 $250.82 $256.50 +12,317%
October, 2029 $240.75 $240.93 $246.85 +11,818%
November, 2029 $232.88 $233.41 $236.47 +11,429%
December, 2029 $224.87 $225.04 $228.74 +11,032%

Enveric Biosciences Inc Stock (ENVB) Price Forecast for 2030

Enveric Biosciences Inc Stock (ENVB) is expected to reach an average price of $165.73 in 2030, with a high forecast of $222.21 and a low forecast of $109.25. This signifies an +8,104% surge from the last price of $2.02.
Month Average Low High Change from today's price
January, 2030 $215.01 $215.06 $222.21 +10,544%
February, 2030 $206.44 $206.51 $212.69 +10,120%
March, 2030 $197.62 $197.91 $204.07 +9,683%
April, 2030 $189.52 $189.56 $195.37 +9,282%
May, 2030 $177.33 $177.50 $187.16 +8,679%
June, 2030 $168.36 $168.42 $174.81 +8,234%
July, 2030 $157.79 $157.88 $165.94 +7,711%
August, 2030 $149.06 $149.09 $155.36 +7,279%
September, 2030 $139.24 $139.56 $146.40 +6,793%
October, 2030 $125.90 $126.00 $136.89 +6,133%
November, 2030 $117.34 $117.64 $122.79 +5,709%
December, 2030 $109.12 $109.25 $114.93 +5,302%
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
Cap:     |  Volume (24h):